Clinical trial for HR positive BC or TNBC, MBC

Options
Moderators
Moderators Member Posts: 25,912
edited February 2018 in Stage IV/Metastatic Breast Cancer ONLY

Open Trials Women's Malignancies Branch, NCI/NIH

Contact: Alexandra Zimmer, MD

alexandra.zimmer@nih.gov


ONC201 (NCT03394027) https://www.clinicaltrials.gov/ct2/show/NCT03394027?term=onc201&draw=2&rank=12

Phase 2 trial with an oral agent taken once a week

Patients: HR positive BC or TNBC with metastatic disease

Requires: tumor biopsies by IR and measurable disease

Allows: Brain mets asymptomatic or treated >1 month; prior PD-1/L1


· Share on FacebookShare on Twitter

Categories